Copyright
©2010 Baishideng.
World J Hepatol. Jan 27, 2010; 2(1): 8-15
Published online Jan 27, 2010. doi: 10.4254/wjh.v2.i1.8
Published online Jan 27, 2010. doi: 10.4254/wjh.v2.i1.8
Table 1 Results of studies comparing CEUS and US in the detection of liver metastases
Study | n | Study group1 | Gold standard | Type of analysis | Sensitivity | Specificity | ||
US | CEUS | US | CEUS | |||||
Piscaglia et al[33], 2007 | 109 | UK | CT, FNA, follow up | P-by-P2 | 0.77 | 0.95 (23%)3 | ||
Konopke et al[23], 2007 | 100 | K | IOUS | P-by-P | 0.56 | 0.84 (50%) | 0.93 | 0.84 |
Larsen et al[38], 2007 | 365 | UK | FNA, CT, IOUS | P-by-P | 0.69 | 0.80 (16%) | 0.98 | 0.98 |
Janica et al[40], 2007 | 51 | S or K | CT, FNA, follow up | P-by-P | 0.63 | 0.90 (43%) | ||
Dietrich et al[32] | 131 | UK | CT, MRI, FNA, follow up | P-by-P | 0.81 | 0.91 (12%) | ||
Quaia et al[31], 2006 | 253 | S or K | FNA, CT, MRI, IOUS | P-by-P | 0.40 | 0.83 (107%) | 0.63 | 0.84 |
Konopke et al[39], 2005 | 56 | S or K | IOUS, FNA, CT | P-by-P | 0.53 | 0.86 (62%) | 0.89 | 0.89 |
Oldenburg et al[15], 2005 | 40 | S | CT, MRI | L-by-L4 | 0.69 | 0.90 (30%) | ||
Albrecht et al[51], 2003 | 123 | S or K | CT (MRI, IOUS, FNA) | P-by-P | 0.94 | 0.98 (4%) | 0.60 | 0.88 |
Esteban et al[36], 2002 | 27 | K | CT | L-by-L | Found 9.3 metastases pr. patient | Found 18.8 metastases pr. patient | ||
Solbiati et al[52], 2001 | 32 | K | CT | L-by-L | Found in 21 out of 32 patients 10-94 more metastases than US | |||
Bertanik et al[53], 2001 | 28 | K | CT | L-by-L | 0.59 | 0.97 (64%) | ||
Albrecht et al[22], 2001 | 62 | S or K | CT, MRI, IOUS, FNA | P-by-P | 0.92 | 0.97 (5%) | ||
Harvey et al[37], 2000 | 11 | K | CT | L-by-L | Found 9.0 metastases pr. patient | Found 21.8 metastases pr. patient |
Table 2 Enhancement patterns of liver metastases
Tumor entity | Arterial phase | Portal phase | Delayed phase |
Hypovascular metastasis | |||
Typical features | Rim enhancement | Hypo-enhancement | Hypo-/non-enhancement |
Additional features | Complete enhancement | Non-enhancement areas | |
Non-enhancement areas (necrosis) | |||
Hypervascular metastasis | |||
Typical features | Hyper-enhancement, complete | Hypo-enhancement | Hypo-/non-enhancement |
Additional features | Chaotic vessels | ||
Cystic metastasis | |||
Typical features | Hyper-enhancement nodular/rim component | Hypo-enhancement | Hypo-enhancement |
Table 3 Sensitivity of CEUS and CT in detecting liver metastases; an overview of studies
Study | n | Study group1 | Type of CT | Analysis | Gold standard | Sensitivity | Statistic | |
CEUS | CT | |||||||
Quaia et al[31], 2006 | 253 | K or S | 1-slice CT | P-by-P3 | CT, FNA, Follow-up, MRI, IOUS | 0.83 | 0.89 | NS2 |
Larsen et al[34] , 2007 | 365 | S | 4-slice CT | P-by-P | CT, IOUS, CEUS, FNA, surgery resection, follow-up | 0.8 | 0.89 | NS |
Dietrich et al[32] | 131 | UK | Multislice CT in most cases4 | P-by-P | CT, MRI, FNA, follow up | 0.91 | 0.89 | NS |
Piscaglia et al[33], 2007 | 109 | S | 1-or 4-slice CT | P-by-P | CT, US, FNA, Follow-up | 0.95 | 0.91 | NS |
Janica et al[40], 2007 | 51 | K or S | Not described | L-by-L5 | FNA, surgical resection, CT and follow-up | 0.9 | 0.78 | NS |
Konopke et al[39], 2005 | 56 | S or K | 1-, 4- or 16-slice CT | P-by-P | IOUS, FNA, CT | 0.86 | 0.76 | NS |
- Citation: Larsen LPS. Role of contrast enhanced ultrasonography in the assessment of hepatic metastases: A review. World J Hepatol 2010; 2(1): 8-15
- URL: https://www.wjgnet.com/1948-5182/full/v2/i1/8.htm
- DOI: https://dx.doi.org/10.4254/wjh.v2.i1.8